InvestorsHub Logo
Followers 415
Posts 6561
Boards Moderated 0
Alias Born 01/07/2014

Re: EOT post# 45178

Monday, 03/09/2020 3:21:54 PM

Monday, March 09, 2020 3:21:54 PM

Post# of 113741
Adva-27a is Sunshine Biopharma's proprietary anticancer compound. In vitro tests conducted on Adva-27a have demonstrated the drug's effectiveness at destroying Multidrug Resistant Cancer Cells including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.


$SBFM

We Want To Perceive Ourselves As Winners, But Successful Traders Are Always Focusing On Their Losses.
--Peter Borish

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News